- Low
- 75,000
- Average
- 75,000
- Median
- 75,000
- High
- 75,000
Targacept Salary
54
11
93
Targacept average salary is $75,000, median salary is $75,000 with a salary range from $75,000 to $75,000.
Targacept salaries are collected from government agencies and companies. Each salary is associated with a real job position. Targacept salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Targacept salaries are collected from government agencies and companies. Each salary is associated with a real job position. Targacept salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
| Software Developer | 75,000-75,000 | WINSTON SALEM, NC, 27101 | 2012 | Targacept Software Developer Salaries (1) Targacept WINSTON SALEM, NC Salaries |
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Targacept salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Guyp Salary Targacept Jobs
| See more Targacept Jobs» | |
| Search All Jobs | |
Targacept... Information
- Targacept Inc
- Industry: BioTech/Drugs
- City: Winston-Salem, NC
- Targacept was established in 1997 as a wholly owned subsidiary of R.J.Reynolds Tobacco Company (NYSE: RJR). It was spun out in August 2000, in oneof the largest ($30.4 million) first-round venture capital financings in U.S.biotech history and the largest in North Carolina biotech history. Targacepthas product candidates in development for treating Alzheimer's disease,Parkinson's disease, ulcerative colitis, depression, pain and Lewy bodydementia, among others. The company has strategic alliances with AventisPharmaceuticals of Strasbourg, France and Dr. Falk Pharma of Freiburg, Germanyto develop and commercialize Targacept compounds.
